The healthcare landscape is undergoing a seismic shift as Artificial Intelligence (AI) moves from experimental research to the frontline of clinical practice. Within this evolution, the AI in Neurology Market stands out as one of the most dynamic sectors, leveraging machine learning to solve some of the most complex puzzles of the human brain.
Market Overview
The integration of AI in Neurology is revolutionizing the diagnosis, treatment, and monitoring of neurological conditions such as Alzheimer’s, Parkinson’s, epilepsy, and acute stroke. By utilizing advanced algorithms to process neuroimaging data (MRI, CT, PET) and real-time brain activity, AI provides clinicians with unprecedented precision.
The global AI in neurology market size was valued at USD 67.29 million in 2024 and is expected to reach USD 1,004.55 million by 2032. This explosive growth represents a CAGR of 40.20% during the forecast period. As we move through 2025, the market is entering a "scaling phase," where pilot programs are transitioning into standard hospital protocols.
Market Share and Size: 2025 Forecast Data
In 2025, the market is projected to be valued at approximately USD 94.34 million, reflecting the initial surge in clinical adoption.
Year | Market Size (USD Million) | Growth Milestone |
2024 | 67.29 | Baseline Adoption |
2025 (Forecast) | 94.34 | Expansion of Clinical SaaS |
2032 (Projected) | 1,004.55 | Mature Market Integration |
North America currently holds the lion’s share of the market (over 41%), driven by a robust R&D infrastructure and early FDA clearances for neurological AI software. However, the Asia-Pacific region is forecasted to grow at the fastest rate through 2032 due to rising healthcare digitization in China and India.
Get a Sample Report of AI in Neurology Forecast @https://www.databridgemarketresearch.com/request-a-sample?dbmr=global-ai-in-neurology-market
Market Segmentation
The AI in neurology market is multifaceted, segmented by technology, indication, and end-user:
1. By Indication
Neuro-technology: Dominates the market (approx. 62% share) through AI-driven neuroimaging and brain-computer interfaces (BCI).
Neurosurgery: The fastest-growing sub-segment, utilizing AI for robotic-assisted procedures and intraoperative navigation.
2. By Application
Screening & Diagnosis: High adoption for early detection of neurodegenerative diseases.
Surgical Planning: AI models create 3D brain maps to minimize risk during delicate procedures.
Rehabilitation: AI-powered wearables track patient recovery and adjust therapy in real-time.
3. By End-User
Hospitals & Clinics: Primary adopters due to high patient volumes.
Research Institutions: Utilizing AI to discover new digital biomarkers.
Do you have any specific queries or need any AI in Neurology Submit your inquiry here @https://www.databridgemarketresearch.com/inquire-before-buying?dbmr=global-ai-in-neurology-market
Key Market Players
The competitive landscape features a mix of medical device giants and specialized AI startups. Notable leaders include:
Medtronic Plc (Ireland): A global leader integrating AI into neurovascular devices and deep brain stimulation (DBS) systems.
Brainomix Limited (U.K.): Renowned for its Brainomix 360 stroke platform, which triples the rate of full recovery in stroke patients.
Caresyntax Corp (U.S.): Focuses on the "smart operating room," using AI to improve surgical outcomes and efficiency.
ActivSurgical Inc. (U.S.): Provides real-time intraoperative visual insights to assist neurosurgeons.
Neosoma Inc. (Israel): Specializes in AI-based neuro-oncology, particularly in monitoring brain tumor progression.
Additional Players: ExplORer Surgical Corp., Surgalign Spine Technology, LeanTaaS Inc., Scalpel Limited, and Theator Inc.
The Role of Predictive Analytics
In neurology, predictive analytics allows doctors to move from reactive to proactive care. By analyzing historical patient data and current imaging, AI can predict the likelihood of a patient developing chronic conditions or suffering a secondary stroke. This capability is the backbone of the "Software-as-a-Service" (SaaS) model currently dominating the 2025 market landscape.
Get A Buy Now Report AI in Neurology Forecast @https://www.databridgemarketresearch.com/checkout/buy/global-ai-in-neurology-market/compare-licence
Future Outlook
The AI in Neurology market is no longer a futuristic concept; it is a burgeoning reality. With a projected valuation of over USD 1 billion by 2032 and a staggering CAGR of 40.20%, the sector is set to redefine brain health. As we look at the 2025 forecast, the focus remains on the "triple aim" of healthcare: improving the patient experience, enhancing population health, and reducing the per capita cost of neurological care. Through the efforts of key players like Medtronic and Brainomix, AI is transforming the most complex organ in the human body into a map that can finally be read with clarity.
About Us:
Data Bridge is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact :
Data Bridge Market Research Private Ltd .
3665 Kingsway - Suite 300 Vancouver BC V5R 5W2 Canada
+1 614 591 3140 (US)
+44 845 154 9652 (UK)
Email: Sales@databridgemarketresearch.com
Website: https://www.databridgemarketresearch.com
Explore More Reports:
polyethylene pe foam film market
railway operation management market
sodium dichloroisocyanurate market
